Synovitis biomarkers: Ex vivo characterization of three biomarkers for identification of inflammatory osteoarthritis

36Citations
Citations of this article
85Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objective: Characterize biomarkers measuring extracellular matrix turnover of inflamed osteoarthritis synovium.Methods: Human primary fibroblast-like synoviocytes and synovial membrane explants (SMEs) treated with various cytokines and growth factors were assessed by C1M, C3M, and acMMP3 in the conditioned medium.Results: TNFα significantly increased C1M up to seven-fold (p = 0.0002), C3M up to 24-fold (p = 0.0011), and acMMP3 up to 14-fold (p < 0.0001) in SMEs. IL-1β also significantly increased C1M up to five-fold (p = 0.00094), C3M four-fold (p = 0.007), and acMMP3 18-fold (p < 0.0001) in SMEs.Conclusion: The biomarkers C1M, C3M, and acMMP-3 were synovitis biomarkers ex vivo and provide a translational tool together with the SME model.

Cite

CITATION STYLE

APA

Kjelgaard-Petersen, C., Siebuhr, A. S., Christiansen, T., Ladel, C., Karsdal, M., & Bay-Jensen, A. C. (2015). Synovitis biomarkers: Ex vivo characterization of three biomarkers for identification of inflammatory osteoarthritis. Biomarkers, 20(8), 547–556. https://doi.org/10.3109/1354750X.2015.1105497

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free